Lactobacillus and Rabeprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lactobacillus (lactobacillus) and Rabeprazole (rabeprazole sodium). Common drug interactions include abdominal discomfort among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Lactobacillus and Rabeprazole. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Lactobacillus?

Lactobacillus has active ingredients of lactobacillus. It is often used in stomach discomfort. eHealthMe is studying from 5,854 Lactobacillus users. Check the latest studies of Lactobacillus.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 24, 2026

18 people who take Lactobacillus and Rabeprazole together, and have interactions are studied.

Lactobacillus and Rabeprazole drug interactions.

What are the common drug interactions of Lactobacillus and Rabeprazole, by gender? *:

female:

  1. Abdominal discomfort
  2. Cerebellar haemorrhage (bleeding in cerebeller)
  3. Fall
  4. Nausea (feeling of having an urge to vomit)
  5. Arthralgia (joint pain)
  6. Autonomic nervous system imbalance (autonomic nervous system is of net equal emphasis)
  7. Blood uric acid increased
  8. Bone pain
  9. Breast cancer
  10. Colitis (inflammation of colon)

male:

  1. Dizziness
  2. Headache (pain in head)
  3. Chills (felling of cold)
  4. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  5. Constipation
  6. Cough
  7. Decreased appetite
  8. Diarrhoea
  9. Dysgeusia (disorder of the sense of taste)
  10. Dyspepsia (indigestion)

What are the common drug interactions of Lactobacillus and Rabeprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Breast cancer

50-59:

  1. Constipation
  2. Abdominal discomfort
  3. Anaemia (lack of blood)
  4. Autonomic nervous system imbalance (autonomic nervous system is of net equal emphasis)
  5. Blood glucose increased
  6. Cough
  7. Diarrhoea
  8. Dizziness
  9. Gamma-glutamyltransferase increased
  10. Gastrointestinal disorder (functional problems of gastrointestinal tract)

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Dizziness
  3. Chills (felling of cold)
  4. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  5. Colitis (inflammation of colon)
  6. Decreased appetite
  7. Diarrhoea
  8. Dysgeusia (disorder of the sense of taste)
  9. Dyspepsia (indigestion)
  10. Dysphonia (speech disorder attributable to a disorder of phonation)

What are the existing conditions these people have? *

  1. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 16.67%
  2. Osteoporosis (bones weak and more likely to break): 2 people, 11.11%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 11.11%
  4. Lung Cancer - Non-Small Cell (lung cancer): 2 people, 11.11%
  5. Multiple Myeloma (cancer of the plasma cells): 2 people, 11.11%
  6. Diabetes: 2 people, 11.11%
  7. High Blood Pressure: 2 people, 11.11%
  8. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 5.56%
  9. Constipation: 1 person, 5.56%
  10. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Lactobacillus and Rabeprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lactobacillus and Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lactobacillus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lactobacillus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rabeprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lactobacillus and rabeprazole sodium (the active ingredients of Lactobacillus and Rabeprazole, respectively), and Lactobacillus and Rabeprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: